Harvie M, Howell A (2017) Potential benefits and harms of intermittent energy restriction and intermittent fasting amongst obese, overweight and normal weight subjects
This compound is part of a class of GLP-1 receptor agonists, which have gained attention for their ability to improve insulin sensitivity and regulate appetite
If you have not yet reviewed your target dose levels, start with our [tirzepatide dosing schedule guide](/guides/tirzepatide-dosing-schedule-complete-guide)
Vanuytsel T, van Wanrooy S, Vanheel H, Vanormelingen C, Verschueren S, Houben E, Salim Rasoel S, Tomicronth J, Holvoet L, Farre R, et al
This requires a balanced, stress-free internal environment
This article explains how each agent works, what the current evidence shows, the safety considerations patients should understand, and how to access emerging obesity treatments safely through regulated NHS and clinical trial pathways